Melanoma is highly aggressive, with brain metastasis being a significant contributor to poor outcomes. Immunotherapy has emerged as a crucial treatment modality for melanoma, particularly for ...

During round 1 surveillance, 43.7% of patients were tested, with 18.2% testing negative for HPV and having NILM cytologic findings, whereas 25.5% had abnormal results. Groups with lower odds of ...